Point-of-care diagnostics in oncology Skip to main content

Point-of-care diagnostics in oncology

Cancer answers at the speed of a pizza delivery

08.10.2026

Brian T. Cunningham and Seemesh Bhaskar examining sample tubes in a laboratory, wearing lab coats, safety glasses and blue gloves. Copyright: Heather Coit/The Grainger College of Engineering

Prof. Cunningham and Seemesh Bhaskar in the BioNano Lab (HMNTL).

The 64-day problem

"The real prize is time. In our own analysis of more than 11,000 lung-cancer patients, the molecular result that guides treatment took an average of 64 days to arrive, and point-of-care testing is about giving that time back to the patient."

From a single snapshot to a movie

"Because these tests are cheap and quick enough to repeat, a single snapshot mailed to a lab becomes a movie: you can watch a therapy working, or catch resistance the day it appears rather than months later."

Why now?

Seemesh Bhaskar and Brian T. Cunningham discussing ideas at a whiteboard covered with scientific sketches. Copyright: Heather Coit/The Grainger College of Engineering

Prof. Cunningham and Seemesh Bhaskar planning the Lab on a Chip ideas in the professor's office (HMNTL).

The gap between a prototype and a product

The hardest barrier – and a reason for optimism

"The technological barriers are being systematically removed, and there are no fundamental physics or chemistry reasons why point-of-care cancer diagnostics can’t become a reality."

The road ahead

Brian T. Cunningham discussing diagrams on a whiteboard with members of the Nanosensors research group gathered around a table. Copyright: Heather Coit/The Grainger College of Engineering

Prof. Cunningham discussing ideas with the Nanosensors group (HMNTL).

What is molecular point-of-care diagnostics in oncology?

Portrait of Jennifer Meyer, a writer for the COMPAMED editorial team, standing in front of a dark, leafy background and looking up; copyright: Jennifer Meyer

Author: Jennifer Meyer | Editorial team MEDICA-tradefair.com

Read also from Genetic Testing & Biomarkers:

Return to top